The Children's Mercy Hospital Research Institute has appointed Tom Curran its chief scientific officer and executive director, effective Feb 1, 2016. Curran comes to Children's Mercy from the Children's Hospital of Philadelphia where he has served as deputy scientific director since 2006 and director of basic scientific research in the center for childhood cancer research since 2007. He also served as professor of pathology and laboratory medicine at the University of Pennsylvania School of Medicine.
Illumina has appointed Frances Arnold to its board of directors. Currently, Arnold manages a research group at the California Institute of Technology and serves as director of the Donna and Benjamin M. Rosen Bioengineering Center. She joined CalTech in 1986 and has served as visiting associate, assistant professor, professor, and director. She currently runs a laboratory at CalTech that focuses on protein engineering by directed evolution with applications in alternative energy, chemicals, and medicine.
Exact Sciences has appointed John Fallon to its board of directors. Most recently, he served as senior vice president and chief physician executive at Blue Cross Blue Shield (BCBS) of Massachusetts from 2004 through 2015. Prior to his role at BCBS, Fallon served as CEO for clinical affairs at the State University of New York Downstate Medical Center, including University Hospital of Brooklyn and the clinical faculty practice plan. Fallon was also the founder and CEO of North Shore Health System, a large physician-hospital organization in Massachusetts. He currently serves on the boards of directors of Insulet and AMAG Pharmaceuticals. He also serves as chair on several not-for-profit boards, including the Network for Excellence in Health Innovation and the National Committee for Quality Assurance Medical Standards, as well as members of the boards for the New England Comparative Effectiveness Public Advisory Council and Temple University School of Medicine Board of Advisors.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.